Wearable Patch Market by Product (Temperature Patch, Blood Glucose Patch, Blood Pressure Patch, Heart Rate Patch & ECG Patch, Skin Care Patch, and Others) and End Use (Healthcare and Fitness and Sports): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4621417
- 206 Pages
- March 2021
- Medical Devices
Wearable patch, also known as smart patch or electronic skin, is used for disease monitoring, drug delivery, and diagnosis applications. Wearable patches help to maintain health and wellbeing in elderly patients suffering from chronic conditions such as diabetes and cardiovascular diseases.
Growth of the global wearable patch market is majorly driven by rise in technological advancements in wearable patches, increase in prevalence of chronic diseases, and growth in awareness among consumers regarding wearable patches. For instance, according to the International Diabetes Federation (IDF), worldwide prevalence of diabetes in 2019 was around 463 million individuals, and is anticipated to reach to 700 million by 2045. Hence, increase in incidences of diabetes is expected to propel demand for wearable patches, which, in turn, propels the market growth. In addition, the connected wearable patches are gaining traction across the world owing to rise in adoption of connectivity technologies, namely, microprocessor controller, Bluetooth, and myoelectric technology.
Moreover, high cost of sensor patches along with concerns regarding data privacy and security are anticipated to restrain the market growth during the forecast period. High cost of sensor monitoring patches in emerging economies such as India, China, and Brazil is expected to impede the market growth during the forecast period. For instance, average selling price of ECG sensor patch in these countries is between $ 300 and $ 4,500.
Depending on product, the market is segmented into temperature patch, blood glucose patch, blood pressure patch, heart rate patch & ECG patch, skin care patch, and others. The blood glucose patch segment is expected to dominate the market as several patients with diabetes are advised to monitor blood glucose on a regular basis to prevent development of hyperglycemia and hypoglycemia.
By end use, the global wearable patch market is bifurcated into healthcare and fitness and sports. The healthcare segment is expected to lead the market throughout the forecast period as these medical/clinical use wearable patches are intended for diagnosis, treatment, or management of certain diseases.
On regional level, the wearable patch market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America market witnessed dominance, in terms of revenue in 2019, owing to the growth in target diseases, presence of advanced healthcare infrastructure, as well as the presence of key industry participants, including, Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., LifeSignals, Inc., Qualcomm Technologies, Inc., and VitalConnect, Inc. Furthermore, the growth of this region is associated with rise in number of health-conscious individuals along with increase in adoption among athletes, working professionals, and individual consumers.
Moreover, increase in need for implementation and integration of medical devices and healthcare IT solutions, rise in awareness regarding wearable devices, and growth in chronic diseases in Asia-Pacific are expected to support fastest market growth of this region during the forecast period.
Competitive rivalry in the global wearable patch market was observed at high level as major players have focused on the adoption of growth strategies such as product launches, mergers and acquisitions (M&As), and partnerships & collaborations to attain strong position in the competitive market. Key players operating in the global wearable patch market include Abbott Laboratories, iRhythm Technologies, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., L’Oreal Group, LifeSignals, Inc., Medtronic Plc (Zephyr Technology Corporation), Qualcomm Technologies, Inc., VitalConnect, Inc., and VivaLNK.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global wearable patch market size along with the current trends and future estimations to elucidate the imminent investment pockets
• It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global wearable patch market growth
KEY MARKET SEGMENTS
By Product
• Temperature Patch
• Blood Glucose Patch
• Blood Pressure Patch
• Heart Rate Patch & ECG Patch
• Skin Care Patch
• Others
By End Use
• Healthcare
• Fitness and Sports
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
List of key players profiled in the report
• Abbott Laboratories
• iRhythm Technologies, Inc.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• L’Oreal Group
• LifeSignals, Inc.
• Medtronic Plc (Zephyr Technology Corporation)
• Qualcomm Technologies, Inc.
• VitalConnect, Inc.
• VivaLNK
List of other players in the value chain (profiles not included in the report):
• Delta Electronics Inc.
• Gentag Inc.
• Nemaura Medical Inc.
• Insulet Corp.
• UpRight Technologies Ltd.
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increasing technological advancements in wearable patch
3.5.1.2.Growing awareness among consumers regarding wearable patch
3.5.1.3.Rising prevalence of chronic diseases
3.5.1.4.Increased demand for the connected wearable patches
3.5.2.Restraints
3.5.2.1.High cost of sensor patch
3.5.2.2.Concerns regarding data privacy and security
3.5.3.Opportunity
3.5.3.1.Increase in adoption of telehealth
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on wearable patch market
CHAPTER 4:WEARABLE PATCH MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Temperature patch
4.2.1.Market size and forecast, by region
4.2.2.Market analysis, by country
4.3.Blood glucose patch
4.3.1.Market size and forecast, by region
4.3.2.Market analysis, by country
4.4.Blood pressure patch
4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country
4.5.Heart rate patch & ECG patch
4.5.1.Market size and forecast, by region
4.5.2.Market analysis, by country
4.6.Skin care patch
4.6.1.Market size and forecast, by region
4.6.2.Market analysis, by country
4.7.Others
4.7.1.Market size and forecast, by region
4.7.2.Market analysis, by country
CHAPTER 5:WEARABLE PATCH MARKET, BY END USE
5.1.Overview
5.1.1.Market size and forecast
5.2.Healthcare
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Fitness and sports
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:WEARABLE PATCH MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.North America market size and forecast, by product
6.2.2.North America market size and forecast, by end use
6.2.3.North America market size and forecast, by country
6.2.4.U.S.
6.2.4.1.U.S. market size and forecast, by product
6.2.4.2.U.S. market size and forecast, by end use
6.2.5.Canada
6.2.5.1.Canada market size and forecast, by product
6.2.5.2.Canada market size and forecast, by end use
6.2.6.Mexico
6.2.6.1.Mexico market size and forecast, by product
6.2.6.2.Mexico market size and forecast, by end use
6.3.Europe
6.3.1.Europe market size and forecast, by product
6.3.2.Europe market size and forecast, by end use
6.3.3.Europe market size and forecast, by country
6.3.4.Germany
6.3.4.1.Germany market size and forecast, by product
6.3.4.2.Germany market size and forecast, by end use
6.3.5.France
6.3.5.1.France market size and forecast, by product
6.3.5.2.France market size and forecast, by end use
6.3.6.UK
6.3.6.1.UK market size and forecast, by product
6.3.6.2.UK market size and forecast, by end use
6.3.7.Italy
6.3.7.1.Italy market size and forecast, by product
6.3.7.2.Italy market size and forecast, by end use
6.3.8.Spain
6.3.8.1.Spain market size and forecast, by product
6.3.8.2.Spain market size and forecast, by end use
6.3.9.Rest of Europe
6.3.9.1.Rest of Europe market size and forecast, by product
6.3.9.2.Rest of Europe market size and forecast, by end use
6.4.Asia-Pacific
6.4.1.Asia-Pacific market size and forecast, by product
6.4.2.Asia-Pacific market size and forecast, by end use
6.4.3.Asia-Pacific market size and forecast, by country
6.4.4.Japan
6.4.4.1.Japan market size and forecast, by product
6.4.4.2.Japan market size and forecast, by end use
6.4.5.China
6.4.5.1.China market size and forecast, by product
6.4.5.2.China market size and forecast, by end use
6.4.6.Australia
6.4.6.1.Australia market size and forecast, by product
6.4.6.2.Australia market size and forecast, by end use
6.4.7.India
6.4.7.1.India market size and forecast, by product
6.4.7.2.India market size and forecast, by end use
6.4.8.South Korea
6.4.8.1.South Korea market size and forecast, by product
6.4.8.2.South Korea market size and forecast, by end use
6.4.9.Rest of Asia-Pacific
6.4.9.1.Rest of Asia-Pacific market size and forecast, by product
6.4.9.2.Rest of Asia-Pacific market size and forecast, by end use
6.5.LAMEA
6.5.1.LAMEA market size and forecast, by product
6.5.2.LAMEA market size and forecast, by end use
6.5.3.LAMEA market size and forecast, by country
6.5.4.Brazil
6.5.4.1.Brazil market size and forecast, by product
6.5.4.2.Brazil market size and forecast, by end use
6.5.5.Saudi Arabia
6.5.5.1.Saudi Arabia market size and forecast, by product
6.5.5.2.Saudi Arabia market size and forecast, by end use
6.5.6.South Africa
6.5.6.1.South Africa market size and forecast, by product
6.5.6.2.South Africa market size and forecast, by end use
6.5.7.Rest of LAMEA
6.5.7.1.Rest of LAMEA market size and forecast, by product
6.5.7.2.Rest of LAMEA market size and forecast, by end use
CHAPTER 7:COMPANY PROFILES
7.1.Abbott Laboratories
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.iRhythm Technologies, Inc.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.Johnson & Johnson Services, Inc.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.Koninklijke Philips N.V.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.L’Oreal Group
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.LifeSignals, Inc.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Key strategic moves and developments
7.7.Medtronic plc (Zephyr Technology Corporation)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.Qualcomm Technologies, Inc.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.9.VitalConnect , Inc.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Key strategic moves and developments
7.10.VivaLNK
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
TABLE 01.GLOBAL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.GLOBAL WEARABLE PATCH MARKET FOR TEMPERATURE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 03.GLOBAL WEARABLE PATCH MARKET FOR BLOOD GLUCOSE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL WEARABLE PATCH MARKET FOR BLOOD PRESSURE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 05.GLOBAL WEARABLE PATCH MARKET FOR HEART RATE PATCH & ECG PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 06.GLOBAL WEARABLE PATCH MARKET FOR SKIN CARE PATCH, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL WEARABLE PATCH MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL WEARABLE PATCH MARKET, BY END USE, 2019–2027 ($MILLION)
TABLE 09.GLOBAL WEARABLE PATCH MARKET FOR HEALTHCARE, BY REGION, 2019–2027 ($MILLION)
TABLE 10.GLOBAL WEARABLE PATCH MARKET FOR FITNESS AND SPORTS, BY REGION, 2019–2027 ($MILLION)
TABLE 11.WEARABLE PATCH MARKET, BY REGION, 2019–2027, ($MILLION)85
TABLE 12.NORTH AMERICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 15.U.S. WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 16.U.S. WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 17.CANADA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 18.CANADA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 19.MEXICO WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 20.MEXICO WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 21.EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 22.EUROPE WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 23.EUROPE WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 24.GERMANY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 25.GERMANY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 26.FRANCE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 27.FRANCE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 28.UK WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 29.UK WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 30.ITALY WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 31.ITALY WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 32.SPAIN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 33.SPAIN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 34.REST OF EUROPE WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 35.REST OF EUROPE WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 36.ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 37.ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 38.ASIA-PACIFIC WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 39.JAPAN WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 40.JAPAN WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 41.CHINA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 42.CHINA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 43.AUSTRALIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 44.AUSTRALIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 45.INDIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 46.INDIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 47.SOUTH KOREA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 48.SOUTH KOREA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 51.LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 52.LAMEA WEARABLE PATCH MARKET, BY END USE, 2019–2027, ($MILLION)
TABLE 53.LAMEA WEARABLE PATCH MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 54.BRAZIL WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 55.BRAZIL WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 56.SAUDI ARABIA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 57.SAUDI ARABIA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 58.SOUTH AFRICA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 59.SOUTH AFRICA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 60.REST OF LAMEA WEARABLE PATCH MARKET, BY PRODUCT, 2019–2027, ($MILLION)
TABLE 61.REST OF LAMEA WEARABLE PATCH MARKET, BY END USE, 2019-2027, ($MILLION)
TABLE 62.ABBOTT: COMPANY SNAPSHOT
TABLE 63.ABBOTT: OPERATING BUSINESS SEGMENTS
TABLE 64.ABBOTT: PRODUCT PORTFOLIO
TABLE 65.IRHYTHM: COMPANY SNAPSHOT
TABLE 66.IRHYTHM: OERATING SEGMENT
TABLE 67.IRHYTHM: PRODUCT PORTFOLIO
TABLE 68.J&J: COMPANY SNAPSHOT
TABLE 69.J&J: OPERATING BUSINESS SEGMENTS
TABLE 70.J&J: PRODUCT PORTFOLIO
TABLE 71.PHILIPS: COMPANY SNAPSHOT
TABLE 72.PHILIPS: OPERATING SEGMENTS
TABLE 73.PHILIPS: PRODUCT PORTFOLIO
TABLE 74.L’OREAL: COMPANY SNAPSHOT
TABLE 75.L’OREAL: OPERATING SEGMENTS
TABLE 76.L’OREAL: PRODUCT PORTFOLIO
TABLE 77.LIFESIGNALS: COMPANY SNAPSHOT
TABLE 78.LIFESIGNALS: OERATING SEGMENT
TABLE 79.LIFESIGNALS: PRODUCT PORTFOLIO
TABLE 80.MEDTRONIC: COMPANY SNAPSHOT
TABLE 81.MEDTRONIC: OPERATING SEGMENTS
TABLE 82.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 83.QUALCOMM: COMPANY SNAPSHOT
TABLE 84.: OERATING SEGMENT
TABLE 85.QUALCOMM: PRODUCT PORTFOLIO
TABLE 86.VITALCONNECT: COMPANY SNAPSHOT
TABLE 87.VITALCONNECT: OERATING SEGMENT
TABLE 88.VITALCONNECT: PRODUCT PORTFOLIO
TABLE 89.VIVALNK: COMPANY SNAPSHOT
TABLE 90.VIVALNK: OERATING SEGMENT
TABLE 91.VIVALNK: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
